Modeling to predict benefit of PRRT in NET patients
Victor Santoro Fernandes, PhD
Active Projects
Molecular mechanisms in the progression of pancreatic neuroendocrine tumors
Nancy Joseph, MD, PhD
New strategies to improve drug development for carcinoid tumors
Emily Bergsland, MD
Novel Therapeutic Vulnerabilities in Cervical Neuroendocrine Carcinoma
Haider S. Mahdi, MD
Optimizing chelator compositions for alpha particle-based PRRT in neuroendocrine tumors
Dongyoul Lee, PhD
PANNET Modeling, Mechanisms, and Experimental Treatment
James Bibb, PhD
PRESCIENT – PET ResponSe CrItEria for Neuroendocrine Tumors
Lisa Bodei, MD, PhD
Reconciling lung carcinoids histopathological and molecular classifications
Matthieu Foll, PhD
Reconstructing the evolutionary history of neuroendocrine tumor subtypes
Nicolas Alcala, PhD
Role of Nrf2 in SBNET drug resistance and development of a novel inhibitor
Po Hien Ear, PhD